Cipla Ltd.

NSE: CIPLA | BSE: 500087 | ISIN: INE059A01026 | Industry: Pharmaceuticals
| Mid-range Performer
1578.2000 18.60 (1.19%)
NSE Sep 18, 2025 15:31 PM
Volume: 874.9K
 

logo
Cipla Ltd.
edited 17 May 2021
1578.20
1.19%
Cipla open to forge a partnership to distribute Covid-19 vaccines in India
Cipla open to forge a partnership to distribute Covid-19 vaccines in India
Business Standard
The company already makes and markets antiviral drugs like remdesivir, favipiravir in India apart from importing and distributing Roche's tocilizumab (Actemra)
Deven Choksey released a Hold report for Cipla Ltd. with a price target of 1570.0 on 08 Sep, 2025.
Coronavirus pandemic | Cipla to expand portfolio for COVID-19 drugs over next two months, says CFO
Moneycontrol | 17 May 2021, 02:29PM 7 more
More from Cipla Ltd.
Recommended
Market closes higher, Ugro Capital gets RBI nod to acquire Profectus Capital
Trendlyne Marketwatch | 18 Sep 2025, 04:03PM
Bull run fizzles out: Multibagger count in Indian equities falls
The Baseline | 18 Sep 2025, 03:38PM
Indian market boosts Cipla in Q4 despite inventory write-off, new product launches will be key
| 20 May 2022